Toward a universal serum antim üllerian hormone threshold as a surrogate for polycystic ovarian morphology on ultrasound: the story is not over…

Although the serum antim üllerian hormone (AMH) assay has been proposed for approximately 20 years to replace or complement the results of transvaginal pelvic ultrasound (TVUS) in women with polycystic ovary syndrome (PCOS), no consensus threshold has been established to date (1). The reasons mainly are technical and metho dologic. In the absence of an international standard, it is impossible to homogenize the results of studies using different assay techniques. In addition, the criteria for selecting patients and control cases vary from one series to another.
Source: Fertility and Sterility - Category: Reproduction Medicine Authors: Tags: Reflections Source Type: research